Study Shows Sperm Concentration Decreased Three Months Following Pfizer’s COVID-19 Vaccinations
In a new study published in the journal Andrology, researchers found what they believe to be a temporary decline of sperm concentration and total motile count among sperm donors in Israel three months following vaccination with Pfizer/BioNTech’s BNT162b2 (also known as “Comirnaty”) messenger RNA (mRNA) COVID-19 biologic.1 Study Investigates the Effect of the Pfizer COVID […]
More Vaccinated, Boosted U.S. Government Leaders Test Positive for Coronavirus
Since The Vaccine Reaction began publishing articles last year (Vaccinated Americans Count Their Blessings Despite Getting COVID and The Vaxxed and Boosted Get COVID But Praise Vaccines for “Mild” Symptoms) tracking members of the U.S. Congress who tested positive for SARS-CoV-2, despite being fully vaccinated and boosted, dozens of additional U.S. Senators and Representatives have tested […]
FDA Panel Recommends EUA for Novavax COVID-19 Vaccine
Despite concerns about the risk of developing myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining of the heart) following vaccination with Novavax’s experimental NVX-CoV2373 (also known as “Nuvaxovid” and “Covovax”) COVID-19 vaccine, the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted on June 6, […]
Guillain-Barré Syndrome Linked to COVID-19 Shots
A study by the University College London showed that serious Guillain-Barré syndrome (GBS), which can result in temporary or permanent paralysis, is a “small but significant” risk associated with AstraZeneca/Oxford University’s AZD1222 (or “Vaxzevria”) vaccine. Of the 996 cases of GBS that were recorded in the United Kingdoms’ National Immunisation Management System database between January […]
Pfizer, Moderna Apply for EUA for COVID Shots for Infants, FDA to Decide Quickly
On June 1, 2022, Pfizer and BioNTech submitted an application to the U.S. Food and Drug Administration (FDA) for an Emergency Use Authorization (EUA) to distribute their messenger RNA (mRNA) BNT162b2 (also known as “Comirnaty”) COVID-19 biologic for children as young as six months to five years old. The application is for a three-dose regimen, […]
Pfizer and Moderna COVID-19 Shots Can Trigger Alopecia Areata in Patients with Autoimmune Conditions
Following the granting by the U.S. Food and Drug Administration (FDA) of Emergency Use Authorization (EUA) status for Pfizer/BioNTech’s BNT162b2 and Moderna/NIAID’s mRNA-1273 messenger RNA (mRNA) COVID-19 biologics in December 2020, there have been increasing reports of alopecia areata following vaccination with these products.1 Alopecia areata is an autoimmune disorder characterized by hair loss due […]